Loading...

Treatment with Sofosbuvir and Daclatasvir (with or without Ribavirin) Improves Patient Reported Outcomes in Hepatitis C

OBJECTIVES: To evaluate the impact of 3 treatment regimens upon health-related quality of life and work productivity using patient-reported outcomes (PROs) in chronic hepatitis C infected patients: sofosbuvir (SOF) + daclatasvir (DCV); SOF + DCV + ribavirin (RBV); SOF + simeprevir (SMV). METHODS: 4...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Osong Public Health Res Perspect
Main Authors: de Medeiros, Lucas Pereira Jorge, Lima, Mario Barreto Correa, Pires, Marcia Maria Amêndola, Maciel, Alessandra Mendonça Almeida, Medeiros, Renata Barboza Vianna, Donadel, Mariana Dermínio, Pereira, Isabela Martins Becattini, Leão, Fábio Marchon, Pires, Luiz Eduardo Amorim Correa Lima, Rzetelna, Helio, Brandão-Mello, Carlos Eduardo
Format: Artigo
Sprog:Inglês
Udgivet: Korea Centers for Disease Control and Prevention 2018
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5935141/
https://ncbi.nlm.nih.gov/pubmed/29740528
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.24171/j.phrp.2018.9.2.03
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!